Healthy Living

Clinical Trials – A New Ray of Hope for Celiac Disease Patients

Innovate biopharmaceuticals (INN-202)

Lastly, Innovate is considered as a well-known clinical-stage biotechnology firm which is privately owned. Its main focus is on crafting novel Gastroenterology drugs. Last February 2016, the said company licensed Alba Therapeutics’ assets (popularly known as INN-202), which demonstrated consistently the reduction of celiac disease’s clinical symptoms in different clinical trials for over 800 patients.